OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs
Bongyong Lee, Iqbal Mahmud, Rudramani Pokhrel, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Host–Guest Self‐Assembled Interfacial Nanoarrays for Precise Metabolic Profiling
Yuning Wang, Yu Liu, Shouzhi Yang, et al.
Small (2023) Vol. 19, Iss. 51
Closed Access | Times Cited: 24

Circular RNAs in glioma: Molecular functions and pathological implications
Cheng Tang, Xinyi He, Lintao Jia, et al.
Non-coding RNA Research (2023) Vol. 9, Iss. 1, pp. 105-115
Open Access | Times Cited: 14

Metabolic Dysfunction in New‐Onset Idiopathic Intracranial Hypertension: Identification of Novel Biomarkers
Johanne Juhl Korsbæk, Rigmor Jensen, Dagmar Beier, et al.
Annals of Neurology (2024) Vol. 96, Iss. 3, pp. 595-607
Open Access | Times Cited: 6

Recent advances in the use of liquid biopsy to fight central nervous system tumors
Carlos Pilotto Heming, Paulo Niemeyer Filho, Vivaldo Moura‐Neto, et al.
Cancer Treatment and Research Communications (2023) Vol. 35, pp. 100709-100709
Open Access | Times Cited: 10

The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action
Yen My Vuu, Ashraf Kadar Shahib, Mojgan Rastegar
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 914-914
Open Access | Times Cited: 10

Liquid Biopsy for Spinal Tumors: On the Frontiers of Clinical Application
Sze Kiat Tan, Chetan Bettegowda, Stephen Yip, et al.
Global Spine Journal (2025) Vol. 15, Iss. 1_suppl, pp. 16S-28S
Open Access

Alpha/beta values in pediatric medulloblastoma: implications for tailored approaches in radiation oncology
Danny Jazmati, Dennis Sohn, Juliane Hörner‐Rieber, et al.
Radiation Oncology (2025) Vol. 20, Iss. 1
Open Access

Ion suppression correction and normalization for non-targeted metabolomics
Iqbal Mahmud, Bo Wei, Lucas Veillon, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

The Intersections between Neuroscience and Medulloblastoma
Yafei Wang, Ying Yu, Jiahua Yu, et al.
Cancer Letters (2025), pp. 217660-217660
Closed Access

The Tumor Microenvironment of Medulloblastoma: An Intricate Multicellular Network with Therapeutic Potential
Niek van Bree, Margareta Wilhelm
Cancers (2022) Vol. 14, Iss. 20, pp. 5009-5009
Open Access | Times Cited: 16

Cellular immunotherapy for medulloblastoma
Michael Y. Schakelaar, Matthijs Monnikhof, Sandra Crnko, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 4, pp. 617-627
Open Access | Times Cited: 15

Liquid Biopsies for Monitoring Medulloblastoma: Circulating Tumor DNA as a Biomarker for Disease Progression and Treatment Response
Barbara Buccilli, Maria A Rodriguez Molina, Daniela P Redrovan Palomeque, et al.
Cureus (2024)
Open Access | Times Cited: 3

A year in review: brain barriers and brain fluids research in 2022
Richard F. Keep, Hazel C. Jones, Mark G. Hamilton, et al.
Fluids and Barriers of the CNS (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8

AMPK attenuates SHH subgroup medulloblastoma growth and metastasis by inhibiting NF-κB activation
Jing Cai, Yue Wang, Xinfa Wang, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7

Plasma ctDNA Monitoring of a PTCH1-Mutant Metastatic Adult Medulloblastoma Showing a Durable Benefit With Vismodegib
Santiago Cabezas-Camarero, Vanesa Garcı́a, Rebeca Pérez‐Alfayate, et al.
The Oncologist (2024) Vol. 29, Iss. 5, pp. 377-383
Open Access | Times Cited: 2

Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review
Kurt Lehner, Kelly Jiang, Jordina Rincón-Torroella, et al.
Neoplasia (2022) Vol. 35, pp. 100852-100852
Open Access | Times Cited: 11

Medulloblastoma: From TP53 Mutations to Molecular Classification and Liquid Biopsy
Robert H. Eibl, Markus Schneemann
Biology (2023) Vol. 12, Iss. 2, pp. 267-267
Open Access | Times Cited: 6

Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification
Jyotirmayee Talapatra, Mamatha M. Reddy
Cancers (2023) Vol. 15, Iss. 7, pp. 2144-2144
Open Access | Times Cited: 6

Surviving the hunger games: Metabolic reprogramming in medulloblastoma
Lorenzo Manfreda, Elena Rampazzo, Luca Persano, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115697-115697
Open Access | Times Cited: 5

miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4
Menglang Yuan, Iqbal Mahmud, Keisuke Katsushima, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 5

LC–MS-Based Urine Metabolomics Analysis for the Diagnosis and Monitoring of Medulloblastoma
Xiaoyan Liu, Jing Li, Xiaolei Hao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8

Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma
Veronica Marabitti, Manuela Giansanti, Francesca De Mitri, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 7

Liquid biopsy for monitoring medulloblastoma
Robert H. Eibl, Markus Schneemann
Extracellular Vesicles and Circulating Nucleic Acids (2022) Vol. 3, Iss. 3, pp. 263-74
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top